AJDRAJNR - American Journal of Neuroradiology

Publication Preview: Published July 10, 2008

American Journal of Neuroradiology 2008;29:1658.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajnr.A1229v1
29/9/1658    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rim, N.-J.
Right arrow Articles by Kim, S.Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rim, N.-J.
Right arrow Articles by Kim, S.Y.

American Journal of Neuroradiology
DOI 10.3174/ajnr.A1229

BRAIN

Which CT Perfusion Parameter Best Reflects Cerebrovascular Reserve?: Correlation of Acetazolamide-Challenged CT Perfusion with Single-Photon Emission CT in Moyamoya Patients

N.-J. Rim, H.S. Kim, Y.S. Shin and S.Y. Kim

From the Departments of Diagnostic Radiology (N.-J.R., H.S.K., S.Y.K.) and Neurosurgery (Y.S.S.), Ajou University School of Medicine, Gyeonggi-do, Korea.

Please address correspondence to Ho Sung Kim, Department of Diagnostic Radiology, Ajou University School of Medicine, Mt 5, Woncheon-dong, Yeongtong-gu, Suwon-si, Gyeonggi-do, 442–749, Korea; E-mail: J978005{at}lycos.co.kr

BACKGROUND AND PURPOSE: CT perfusion (CTP) is a more readily accessible method for evaluation of cerebral perfusion than single-photon emission CT (SPECT). We assessed whether there is any resting or drug-challenged CTP parameter correlating with cerebrovascular reserve (CVR) obtained by SPECT in Moyamoya patients.

MATERIALS AND METHODS: Normalized baseline CTP parameters and their percentage changes were calculated in 152 regions of interest (ROIs). On qualitative SPECT analysis, each ROI was classified in either the "impaired CVR" or "normal CVR" group. Quantitative CVR was calculated by using normalized SPECT values before and after acetazolamide administration. Baseline CTP parameters and their percentage changes were compared with qualitative and quantitative CVRs. Receiver operating characteristic (ROC) curve analysis defined the threshold values of CTP parameters that best predict impaired qualitative CVR.

RESULTS: The mean values of CTP parameters were significantly different between normal and impaired CVR groups. The percentage change of cerebral blood flow (pcCBF) was correlated most significantly with quantitative CVR (r = 0.89; P < .05). The correlation coefficients between the baseline CTP parameters and quantitative CVR were poor or not significant. The ROC-derived threshold values of pcCBF and mean transit time determined impaired CVR with a sensitivity of 94.4 and 85.2; specificity of 93.2 and 65.9; positive predictive value of 97.1 and 86.0; and negative predictive value of 87.2 and 64.4, respectively.

CONCLUSION: Baseline CTP parameters are not reliable for predicting impaired CVR. However, pcCBF correlated strongly with quantitative CVR; therefore, CTP evaluation for CVR in Moyamoya patients requires normalization and acetazolamide challenge.




This article has been cited by other articles:


Home page
 Am. J. Neuroradiol.Home page
A.S. Vagal, J.L. Leach, M. Fernandez-Ulloa, and M. Zuccarello
The Acetazolamide Challenge: Techniques and Applications in the Evaluation of Chronic Cerebral Ischemia
AJNR Am. J. Neuroradiol., May 1, 2009; 30(5): 876 - 884.
[Abstract] [Full Text] [PDF]


Copyright © 2009 by the American Society of Neuroradiology. Print ISSN: 0195-6108 Online ISSN: 1936-959X